Bahati YL, Delanghe J, Balaluka GB, Vandepoele K, Cirhuza JC, Kishabongo AS, Philippé J. Ferroportin Q248H mutation was not found to be protective against malaria and anemia in children under 5 years living in South Kivu/Democratic Republic of Congo, an endemic area of Plasmodium infection.
Heliyon 2022;
8:e10460. [PMID:
36060466 PMCID:
PMC9437791 DOI:
10.1016/j.heliyon.2022.e10460]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Revised: 02/21/2022] [Accepted: 08/22/2022] [Indexed: 10/31/2022] Open
Abstract
Background
Materials and methods
Results
Conclusion
Frequency of ferroportin Q248H is high in African population.
Ferroportin has been described to protect red blood cells against oxidative stress and malaria infection.
Ferroportin allele frequency was similar in anemic and non-anemic children.
No difference according to ferroportin allele frequency was observed among children in endemic area of Plasmodium infection.
Ferroportin Q248H mutation, G6PD deficiency and sickle cell anemia did not affect susceptibility to malaria in endemic area.
Collapse